Description: PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, neuropsychiatric, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is headquartered in Chongqing, China.
Home Page: www.pku-hc.com
Liangjiangtiandi
Chongqing,
400000
China
Phone:
86 23 6750 2832
Officers
| Name | Title |
|---|---|
| Mr. Ping Dong Yuan | Pres & Non-Independent Director |
| Mr. Quan Bo Zhao | Chief Financial Officer |
| Mr. Yu Meng Chuan | VP |
| Mr. Yuan Yu Fei | Sec. of the Board |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 123.3333 |
| Price-to-Book MRQ: | 3.7743 |
| Price-to-Sales TTM: | 2.5913 |
| IPO Date: | 1997-05-27 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |